Article
SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir.
The Journal of antimicrobial chemotherapy - 1 Apr 2015
Milazzo Laura, Peri Anna Maria, Mazzali Cristina, Magni Carlo, Calvi Elisa, De Nicolò Amedeo, Clementi Emilio, Cheli Stefania, D'Avolio Antonio, Antinori Spinello, Falvella Felicia Stefania
Abstract excerpt
OBJECTIVES: The equilibrative nucleoside transporter 1 (ENT1) is the main protein involved in ribavirin cellular uptake. Polymorphisms at the SLC29A1 gene, encoding ENT1, may influence ribavirin-associated anaemia, which is observed at a higher incidence with telaprevir in combination with pegylated-IFNα and ribavirin than with pegylated-IFNα and ribavirin alone. In this study, we investigated the role of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
